SEC Form 5 · accession 0001185185-16-004492
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Mar 31, 2016
Accepted (ET)
May 12, 2016 · 11:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Oct 30, 2015 | G | 2,000 | $0.00 | D | 234,000 | D | |
| Common stock | Nov 6, 2015 | G | 2,000 | $0.00 | D | 232,000 | D | |
| Common stock | Nov 13, 2015 | G | 2,000 | $0.00 | D | 230,000 | D | |
| Common stock | Nov 20, 2015 | G | 2,000 | $0.00 | D | 228,000 | D | |
| Common stock | Nov 27, 2015 | G | 2,000 | $0.00 | D | 226,000 | D | |
| Common stock | Dec 4, 2015 | G | 2,000 | $0.00 | D | 224,000 | D | |
| Common stock | Dec 11, 2015 | G | 2,000 | $0.00 | D | 222,000 | D | |
| Common stock | Dec 18, 2015 | G | 2,000 | $0.00 | D | 220,000 | D | |
| Common stock | Dec 28, 2015 | G | 2,000 | $0.00 | D | 218,000 | D | |
| Common stock | Jan 8, 2016 | G | 2,000 | $0.00 | D | 216,000 | D | |
| Common stock | Jan 15, 2016 | G | 2,000 | $0.00 | D | 214,000 | D | |
| Common stock | Jan 22, 2016 | G | 2,000 | $0.00 | D | 212,000 | D | |
| Common stock | Jan 29, 2016 | G | 2,000 | $0.00 | D | 210,000 | D | |
| Common stock | Feb 5, 2016 | G | 2,000 | $0.00 | D | 208,000 | D | |
| Common stock | Feb 12, 2016 | G | 2,000 | $0.00 | D | 206,000 | D | |
| Common stock | Feb 19, 2016 | G | 2,000 | $0.00 | D | 204,000 | D | |
| Common stock | Feb 26, 2016 | G | 2,000 | $0.00 | D | 202,000 | D | |
| Common stock | Mar 7, 2016 | G | 2,000 | $0.00 | D | 200,000 | D | |
| Common stock | Mar 11, 2016 | G | 2,000 | $0.00 | D | 198,000 | D | |
| Common stock | Mar 18, 2016 | G | 2,000 | $0.00 | D | 196,000 | D | |
| Common stock | Mar 29, 2016 | G | 2,000 | $0.00 | D | 194,000 | D | |
| Common stockF1 | Mar 31, 2016 | A | 125,000 | $0.00 | D | 319,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.